Search research articles
Contact Us
Filters
Showing results (21-30 of 63) with videos related to
Page
of 7
Sort By:
Bulletin Du Cancer
|
December 13, 2023
[Optimizing the use of bosutinib in patients with chronic-phase chronic myeloid leukemia: Recommendations of a panel of experts from the Fi-LMC (French CML working group)]
Delphine Rea, Emilie Cayssials, Aude Charbonnier, et al.
Haematologica
|
August 13, 2016
Uncoupling of the Hippo and Rho pathways allows megakaryocytes to escape the tetraploid checkpoint
Anita Roy, Larissa Lordier, Catherine Pioche-Durieu, et al.
Annals of Hematology
|
January 8, 2025
Asciminib resistance of a new BCR::ABL1 p.I293_K294insSSLRD mutant detected in a Ph + ALL patient
Grégoire Cullot, Valérie Lagarde, Jean-Michel Cayuela, et al.
European Journal of Immunology
|
May 16, 2012
Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients
Alexis Rossignol, Anaïs Levescot, Florence Jacomet, et al.
European Journal of Immunology
|
April 24, 2015
Evidence for eomesodermin-expressing innate-like CD8(+) KIR/NKG2A(+) T cells in human adults and cord blood samples
Florence Jacomet, Emilie Cayssials, Sara Basbous, et al.
Oncotarget
|
March 10, 2016
P53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesis
Emna Mahfoudhi, Larissa Lordier, Caroline Marty, et al.
Annals of Hematology
|
May 24, 2025
Subclonal emergence of polycythemia vera, chronic myelomonocytic leukemia, and chronic myeloid leukemia
Violaine Tran Quang, Jules Cretin, Romain Loyaux, et al.
Frontiers in Immunology
|
February 1, 2017
The Hypothesis of the Human iNKT/Innate CD8(+) T-Cell Axis Applied to Cancer: Evidence for a Deficiency in Chronic Myeloid Leukemia
Florence Jacomet, Emilie Cayssials, Alice Barbarin, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 30, 2010
The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge
Franck E Nicolini, Jean-Claude Chomel, Lydia Roy, et al.
Journal of Hematology & Oncology
|
March 19, 2022
Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
Mathieu Leclerc, Rabah Redjoul, Anne Le Bouter, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 63) with videos related to
Sort By:
Page
of 7
Bulletin Du Cancer
|
December 13, 2023
[Optimizing the use of bosutinib in patients with chronic-phase chronic myeloid leukemia: Recommendations of a panel of experts from the Fi-LMC (French CML working group)]
Delphine Rea, Emilie Cayssials, Aude Charbonnier, et al.
Haematologica
|
August 13, 2016
Uncoupling of the Hippo and Rho pathways allows megakaryocytes to escape the tetraploid checkpoint
Anita Roy, Larissa Lordier, Catherine Pioche-Durieu, et al.
Annals of Hematology
|
January 8, 2025
Asciminib resistance of a new BCR::ABL1 p.I293_K294insSSLRD mutant detected in a Ph + ALL patient
Grégoire Cullot, Valérie Lagarde, Jean-Michel Cayuela, et al.
European Journal of Immunology
|
May 16, 2012
Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients
Alexis Rossignol, Anaïs Levescot, Florence Jacomet, et al.
European Journal of Immunology
|
April 24, 2015
Evidence for eomesodermin-expressing innate-like CD8(+) KIR/NKG2A(+) T cells in human adults and cord blood samples
Florence Jacomet, Emilie Cayssials, Sara Basbous, et al.
Oncotarget
|
March 10, 2016
P53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesis
Emna Mahfoudhi, Larissa Lordier, Caroline Marty, et al.
Annals of Hematology
|
May 24, 2025
Subclonal emergence of polycythemia vera, chronic myelomonocytic leukemia, and chronic myeloid leukemia
Violaine Tran Quang, Jules Cretin, Romain Loyaux, et al.
Frontiers in Immunology
|
February 1, 2017
The Hypothesis of the Human iNKT/Innate CD8(+) T-Cell Axis Applied to Cancer: Evidence for a Deficiency in Chronic Myeloid Leukemia
Florence Jacomet, Emilie Cayssials, Alice Barbarin, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 30, 2010
The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge
Franck E Nicolini, Jean-Claude Chomel, Lydia Roy, et al.
Journal of Hematology & Oncology
|
March 19, 2022
Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
Mathieu Leclerc, Rabah Redjoul, Anne Le Bouter, et al.
Page
of 7